Shares of Alliance Pharma plc (LON:APH) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as low as $70.71. Alliance Pharma shares last traded at $71.90, with a volume of 141,025 shares.
Separately, Numis Securities restated a “buy” rating on shares of Alliance Pharma in a report on Monday, June 3rd.
The firm’s fifty day moving average price is GBX 69.97 and its 200 day moving average price is GBX 71.78. The company has a current ratio of 0.64, a quick ratio of 0.39 and a debt-to-equity ratio of 39.31. The stock has a market capitalization of $371.38 million and a price-to-earnings ratio of 20.03.
Alliance Pharma Company Profile (LON:APH)
Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.